The Latest

Whether you're a patient, clinician, retailer or researcher, come with us as we work to bring quality, accessible cannabis care (and data) to all.

Featured

News

EO Care, Inc. Statement on Cannabinoid Policy Announcements

December 18, 2025

EO Team

The Administration’s decision to move to reclassify cannabis from Schedule I to Schedule III is a watershed moment for adult Americans who currently or might benefit from the responsible use of cannabinoids, especially oncology patients and older adults. It’s a long overdue step that will reduce stigma, open doors for essential research and product development, and increase access to care for patients.

News

EO Data & Methodology: November 2025 Update

At EO, we systematically track how patients feel and function after starting guided cannabis care. The data below come from real people using cannabis to manage symptoms such as pain, sleep disturbance, anxiety, and nausea/vomiting, under the guidance of our clinical protocols.

News

EO Care Releases Latest Cannabinoid-Based Symptom Management Efficacy Data

Meaningful improvements were reported by patients after one (1) week and sustained through four (4) weeks of guided cannabinoid care, particularly among people over 50 and cancer patients. Patients also reported low rates of use-limiting side effects with further reductions after receiving updated recommended product and/or dosing guidance via EO Care’s digital care platform.

Education

THC for Sleep: Benefits and Uses

Explore the importance of sleep and how THC and other cannabinoids can gently address modern sleep challenges.

Education

Cannabis and Cancer

Navigating a cancer diagnosis is one of the most difficult life challenges a person can face. Two-time cancer survivor and EO spokesperson Ethan Zohn says, “cancer is a disease that touches every part of you as a human being: mental, physical, social, spiritual. You’re always just looking for ways to make yourself feel better.”

Education

Gabapentin and THC

Gabapentin and cannabis are two substances frequently used to help manage pain and a range of other health conditions. While gabapentin is primarily used to help treat nerve pain, seizures and shingles-related discomfort, cannabis is well known for its analgesic, anti-inflammatory and relaxation-inducing effects.

Education

THC Inhaler vs Vape

A growing body of research illustrates the untapped potential of cannabis for a range of medical uses, like helping to manage pain, stress, sleep and appetite. However, studies also indicate that alternative methods of intake are necessary to create consistent, repeatable effects and to reduce the risks associated with smoking cannabis. According to a scientific review by the Institute of Medicine, “the future of cannabinoid drugs lies not in smoked marijuana but in chemically defined drugs that act on the cannabinoid systems that are a natural component of human physiology.”

Employers

Legal Primer

EO Care operates within a complex but navigable legal framework that allows for nationwide delivery of clinical cannabis guidance through its digital health platform while providing access to federally legal hemp-derived products.

Research

Medical Cannabis: Time to Act

More than ever before, people are using cannabis for medical reasons. In fact, 17% of primary care patients reported using cannabis in a recent cross-sectional study. Of those cannabis users, 15.6% reported using...

Research

Cannabis for Cancer Symptom Relief: Expert Insights Unveiled by Dr. Brooke Worster

In the quest for relief from the burdens of cancer treatment, individuals often turn to cannabis, seeking answers amidst the chaos of symptoms.

News

Empowering Cancer Patients and their Caregivers: CSC Partners with EO Care for Clinically Guided Cannabis Support

Cancer Support Community (CSC) has teamed up with EO Care, a leader in clinically guided cannabis health solutions, to provide cancer patients, survivors, and their caregivers with comprehensive support.

News

Rescheduling Cannabis to a Schedule III Controlled Substance: A Regulator’s Perspective

Recently, the Department of Health and Human Services recommended that cannabis be reclassified from a Schedule I Controlled Substance to a Schedule III Controlled Substance under the federal Controlled Substances Act. In a PM360 article Rescheduling Cannabis to a Schedule III Controlled Substance: A Regulator’s Perspective,

News

Insight for Employers: Employees Are More Likely to Apply for Jobs Offering Cannabis Benefits

As more states legalize the use of cannabis, it can be challenging for employers to keep up and find reliable information. A recent Benefits Pro article, Employees are more likely to apply for jobs that offer cannabis benefits, shares findings from an EO Care ...

News

Imerman Angels & EO Care: A Partnership to Provide Clinically Guided Cannabis Care and Advice to Members

1 in 2 people will get cancer in their lifetime, and 40% of cancer patients use cannabis for treatment of symptoms. But clinical guidance for cannabis is difficult to find. That’s why Imerman Angels is partnering with EO Care — the first clinically guided cannabis health and wellness solution for employers, payers, and associations — to provide cannabis care and advice to members. ImermanAngels.org visitors will be able to access educational content including whether cannabis is right for them, how to optimize use, and even how to reduce use.

News

Get to Know Ethan Zohn, the Ultimate “Survivor”

Ethan Zohn truly embodies the word “survivor.” In 2001, he won Survivor Africa, the third season of the popular reality TV show — and later became a two-time survivor of a rare blood cancer. At the age of 35 and in the prime of his life, this fit, former professional soccer player was diagnosed with CD20+ Hodgkin’s Lymphoma. Over several years, Ethan endured aggressive treatment including two stem cell transplants.

The Latest

Featured

EO Care, Inc. Statement on Cannabinoid Policy Announcements

EO Data & Methodology: November 2025 Update

EO Care Releases Latest Cannabinoid-Based Symptom Management Efficacy Data

THC for Sleep: Benefits and Uses

Cannabis and Cancer

Gabapentin and THC

THC Inhaler vs Vape

Legal Primer

Medical Cannabis: Time to Act

Cannabis for Cancer Symptom Relief: Expert Insights Unveiled by Dr. Brooke Worster

Empowering Cancer Patients and their Caregivers: CSC Partners with EO Care for Clinically Guided Cannabis Support

Rescheduling Cannabis to a Schedule III Controlled Substance: A Regulator’s Perspective

Insight for Employers: Employees Are More Likely to Apply for Jobs Offering Cannabis Benefits

Imerman Angels & EO Care: A Partnership to Provide Clinically Guided Cannabis Care and Advice to Members

Get to Know Ethan Zohn, the Ultimate “Survivor”

EO in Your Inbox